{"status":"OK","data":{"advertisement":{"id":240887,"title":"Zapytanie Ofertowe Nr 01/WPD101A/2024 pn.: ,,Badania przedkliniczne i kliniczne WPD101a, innowacyjnej terapii nowotwor\u00f3w m\u00f3zgu\u201d \nrealizowane w ramach konkursu nr FENG.01.01-IP.01-005/23 \u015acie\u017cka SMART \u2013 Projekty realizowane w konsorcjach.","partial_offer_allowed":false,"publication_date":"2023-12-31","submission_deadline":"2024-02-02 12:00:00","planned_sign_date":null,"supplementary_orders":"Zamawiaj\u0105cy  nie przewiduje udzielenie zam\u00f3wienia uzupe\u0142niaj\u0105cego/dodatkowego.","terms_of_contract_change":"zosta\u0142y okre\u015blone szczeg\u00f3\u0142owo w tre\u015bci Zapytania Ofertowego","created_at":"2023-12-31 12:10:09","modified_at":"2024-02-02 12:00:03","contact_persons":[{"id":15646,"forename":"Anna","surname":"Szczepa\u0144ska-Buda","phone_number":"+48 693246471","email":"oferty@wpdpharmaceuticals.com","created_by":null,"created_at":"2022-10-07 15:08:02","modified_at":"2023-04-21 14:40:58","modified_by":null}],"orders":[{"id":390872,"estimated_value":null,"order_items":[{"id":440801,"description":"1.\tPrzedmiotem zam\u00f3wienia jest us\u0142uga wytworzenia WPD101A w celu rejestracji produktu leczniczego w EMA/FDA do badania klinicznego fazy 1 podzielona na 2 cz\u0119\u015bci zwane Pakietami okre\u015blone poni\u017cej: \nPakiet 1 \u2013 non-GMP: transfer technologii, wytworzenie RCB, rozw\u00f3j procesowy, rozw\u00f3j analityczny i produkcja bia\u0142ka WPD101A w standardzie non-GMP wraz z testami zwolnieniowymi QC;\nPakiet 2 \u2013 GMP: wytworzenie MCB, opracowanie formulacji, transfer metod analitycznych, transfer technologii, badania stabilno\u015bci, szar\u017ca non-GMP, szar\u017ca GMP, testy zwolnieniowe QC dla bia\u0142ka WPD101A. \n2.\tWykonawca powinien do\u0142o\u017cy\u0107 wszelkich stara\u0144 w celu przewidzenia wysoko\u015bci wszystkich koszt\u00f3w niezb\u0119dnych do zrealizowania celu us\u0142ugi, a wi\u0119c wytworzenia WPD101A w standardzie GMP w celu rejestracji produktu leczniczego w EMA/FDA \ni uzyskania zgody na badanie kliniczne fazy 1.\n","warranty_period":null,"cpv_items":[{"id":8513,"code":"73100000-3","name":"Us\u0142ugi badawcze i eksperymentalno-rozwojowe"}],"timetable_items":[],"fulfillment_places":[{"country":"Polska","voivodeship":null,"poviat":null,"commune":null,"locality":null,"created_by":null,"created_at":"2023-12-31 12:10:09","modified_at":"2023-12-31 18:50:21","modified_by":null,"id":494016,"type":{"id":2,"name":"ca\u0142a Polska"},"group_uuid":"f8fbbd69-1243-4ec1-a46c-56f558ecca94"}],"participation_conditions":[{"id":1205451,"description":"O udzielenie zam\u00f3wienia mog\u0105 ubiega\u0107 si\u0119 Wykonawcy, kt\u00f3rzy nie podlegaj\u0105 wykluczeniu z post\u0119powania o udzielenie zam\u00f3wienia oraz spe\u0142niaj\u0105 warunki udzia\u0142u \nw post\u0119powaniu tj.: wyka\u017c\u0105 si\u0119 posiadaniem do\u015bwiadczenia w postaci 2 przyk\u0142ad\u00f3w us\u0142ug rozwoju technologii wytwarzania bia\u0142ek rekombinowanych o poni\u017cszych parametrach: wydajno\u015b\u0107 kompletnego procesu wytwarzania na poziomie co najmniej 1 g z 1 litra fermentacji bakteryjnej i czysto\u015b\u0107 produktu na poziomie co najmniej 98% (bez ujawniania wra\u017cliwych szczeg\u00f3\u0142\u00f3w takich przyk\u0142ad\u00f3w)","type":{"id":2,"name":"Wiedza i do\u015bwiadczenie"},"created_by":null,"created_at":"2023-12-31 12:10:09","modified_at":"2023-12-31 18:50:21","modified_by":null,"group_uuid":"64d7eab6-d840-4b8a-a2fd-6cf8b7fd7937"}],"category":{"id":1,"name":"Us\u0142uga"},"subcategory":{"id":4,"name":"Us\u0142ugi badawcze"},"created_by":null,"created_at":"2023-12-31 12:10:09","modified_at":"2023-12-31 18:50:21","modified_by":null,"group_uuid":"5e8bb132-90c3-4cdc-a2f0-0c571808bd1c"}],"evaluation_criteria":[{"id":670889,"price_criterion":true,"description":"C = (Cmin/Cbad)  x 100% x 100\nPunkty b\u0119d\u0105 przyznawane wg nast\u0119puj\u0105cych zasad: 1% = 1 punkt.\na) oferta z najni\u017csz\u0105 cen\u0105 brutto otrzyma 100 punkt\u00f3w.\nb) punkty pozosta\u0142ych ofert liczone b\u0119d\u0105 wg proporcji matematycznej z dok\u0142adno\u015bci\u0105 do dw\u00f3ch miejsc po przecinku","created_by":null,"created_at":"2023-12-31 12:10:09","modified_at":"2023-12-31 18:50:21","modified_by":null,"group_uuid":"46887230-13fa-4182-9404-53b7af5c91aa"}],"is_variant":false,"title":"Zapytanie Ofertowe Nr 01/WPD101A/2024 ","order_node":{"id":296577},"created_by":null,"created_at":"2023-12-31 12:10:09","modified_at":"2023-12-31 18:50:21","modified_by":null}],"created_by":{"id":7309,"contact_persons":[]},"modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":2,"label":"PUBLISHED","name":"Opublikowane"},"advertiser_address_details":{"name":"WPD Pharmaceuticals","identification_number_type":"nip","identification_number":"5252721500","address":{"country":"Polska","voivodeship":"mazowieckie","poviat":"Warszawa","commune":"Ochota","locality":"Warszawa","created_by":null,"created_at":null,"modified_at":null,"modified_by":null,"id":638813,"street":"\u017bwirki i Wigury ","number_description":"101","postcode":"02-089"},"created_by":{"id":7309,"contact_persons":[]},"created_at":"2023-12-31 12:10:08","modified_at":"2023-12-31 12:10:08","modified_by":{"id":7309,"contact_persons":[]},"id":241452},"advertisement":{"id":183349,"number":"2023-7309-183349","publication_date":"2023-12-31","created_by":{"id":7309,"contact_persons":[]},"created_at":"2023-12-31 12:10:08","modified_at":"2024-02-02 12:00:03","modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":6,"label":"RESOLVED","name":"Rozstrzygni\u0119te"},"all_available_version_ids":[240887],"enrollment":{"id":43343,"name":"Projekty realizowane w konsorcjach","number":"005/23","activity":{"created_by":null,"created_at":"2023-02-01 09:22:25","modified_at":"2023-02-01 09:22:25","modified_by":null},"region":null,"institution":{"created_by":null,"created_at":"2023-02-01 09:27:55","modified_at":"2023-02-01 09:27:55","modified_by":null},"full_number":"FENG.01.01-IP.01-005/23","perspective":{},"programme":{"created_by":null,"created_at":"2023-02-01 09:21:41","modified_at":"2023-02-01 09:21:41","modified_by":null},"priority":{"created_by":null,"created_at":"2023-02-01 09:21:51","modified_at":"2023-02-01 09:21:51","modified_by":null},"type":"enrollment","created_by":null,"created_at":"2023-12-29 09:05:23","modified_at":"2023-12-29 09:05:23","modified_by":null},"projects":[],"is_author":false,"is_admin":false},"attachments":[{"origin":{"id":240887,"publication_date":"2023-12-31"},"id":1223456,"name":"Zapytanie Ofertowe Nr 01/WPD101A/2024","file":{"id":1363627,"name":"POL ZO 01 WPD101A 2024.pdf","created_at":"2023-12-31 18:45:37","created_by":{"forename":"Anna","surname":"Buda"},"uri":"/api/files/1363627"},"group_uuid":"9945943c-5c9c-44b8-bccd-1d54f7c56353"},{"origin":{"id":240887,"publication_date":"2023-12-31"},"id":1223457,"name":"Request for Quotation No. 01/WPD101A/2024","file":{"id":1363628,"name":"ENG RFP 01 WPD101A 2024.pdf","created_at":"2023-12-31 18:46:30","created_by":{"forename":"Anna","surname":"Buda"},"uri":"/api/files/1363628"},"group_uuid":"a4b657ac-ab6c-4b09-b650-ef1404140efc"},{"origin":{"id":240887,"publication_date":"2023-12-31"},"id":1223458,"name":"OPZ - Pakiet 1","file":{"id":1363629,"name":"POL OPZ 01 WPD101A 2024 - Package 1 (non-GMP).pdf","created_at":"2023-12-31 18:47:13","created_by":{"forename":"Anna","surname":"Buda"},"uri":"/api/files/1363629"},"group_uuid":"f098a0fc-cf01-47e4-a180-59815d5d89cd"},{"origin":{"id":240887,"publication_date":"2023-12-31"},"id":1223459,"name":"OPZ - Pakiet 2","file":{"id":1363630,"name":"POL OPZ 01 WPD101A 2024 - Package 2 (GMP).pdf","created_at":"2023-12-31 18:47:38","created_by":{"forename":"Anna","surname":"Buda"},"uri":"/api/files/1363630"},"group_uuid":"87e06cd8-70d8-477f-aa96-ffcdd62f5b0a"},{"origin":{"id":240887,"publication_date":"2023-12-31"},"id":1223460,"name":"TOR - Package 1","file":{"id":1363631,"name":"ENG TOR 01 WPD101A 2024 - Package 1 (non-GMP).pdf","created_at":"2023-12-31 18:48:05","created_by":{"forename":"Anna","surname":"Buda"},"uri":"/api/files/1363631"},"group_uuid":"5bd625a3-ad26-4964-a3a6-c7e8627c5c1c"},{"origin":{"id":240887,"publication_date":"2023-12-31"},"id":1223461,"name":"TOR - Package 2","file":{"id":1363632,"name":"ENG TOR 01 WPD101A 2024 - Package 2 (GMP).pdf","created_at":"2023-12-31 18:48:47","created_by":{"forename":"Anna","surname":"Buda"},"uri":"/api/files/1363632"},"group_uuid":"59958074-1465-4666-8b3e-a1b0d142a4bf"},{"origin":{"id":240887,"publication_date":"2023-12-31"},"id":1223462,"name":"za\u0142\u0105czniki do pobrania","file":{"id":1363633,"name":"POL Za\u0142\u0105czniki do pobrania.docx","created_at":"2023-12-31 18:49:20","created_by":{"forename":"Anna","surname":"Buda"},"uri":"/api/files/1363633"},"group_uuid":"175c42bc-aa24-4c89-a4a1-a21bb0cc5001"},{"origin":{"id":240887,"publication_date":"2023-12-31"},"id":1223463,"name":"attachments to download","file":{"id":1363634,"name":"ENG Attachments to download.docx","created_at":"2023-12-31 18:49:42","created_by":{"forename":"Anna","surname":"Buda"},"uri":"/api/files/1363634"},"group_uuid":"737ab12c-730a-44f1-ab56-80a27889e1d5"}]},"dictionaries":{"announcement_status_draft":1,"announcement_status_published":2},"favorite":null,"badge":null,"offer_set_badge_count":null,"question_badge_count":null}}